No founder effect in three novel Alzheimer's disease families with APP 717 Val--&gt;Ile mutation. Clerget-darpoux. French Alzheimer's Disease Study Group.

D Campion; A Brice; D Hannequin; F Charbonnier; B Dubois; C Martin; A Michon; C Penet; M Bellis; A Calenda; M Martinez; Y Agid; F Clerget-Darpoux; T Frebourg

doi:10.1136/jmg.33.8.661

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via CCMG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via CCMG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Alerts

Research Article

No founder effect in three novel Alzheimer's disease families with APP 717 Val-->Ile mutation. Clerget-darpoux. French Alzheimer's Disease Study Group.

Log in using your username and password

Main menu

Log in using your username and password

You are here

Read the full text or download the PDF:

Log in using your username and password